Wire Stories
627Global Compound Feed Market (2022 to 2027) – Growth, Trends, COVID-19 Impact and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Compound Feed Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering....
- 513
Global Screenwriter Creation Forum was Held in Changzhi, where Screenwriters Unlocked the Success Mystery of Main Melody Teleplays
MACAU, China–(BUSINESS WIRE)–Recently, as one of the series of events of the World Film Industry Conference and sponsored by Aollywood Group, the...
- 603
SVA FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sinovac Biotech Ltd. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action Against 1Globe Capital LLC and Certain of its Officers – SVA
NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ:...
- 729
Pakistan Construction Industry Report 2022: Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and Residential Market Size, Trends and Forecasts, 2017-2021 & 2022-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Pakistan Construction Market Size, Trends and Forecasts by Sector – Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and Residential Market...
- 501
Australia Construction Industry Report 2022: Analysis, Trends and Forecasts, 2017-2021 & 2022-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Australia Construction Market Size, Trends and Forecasts by Sector – Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and Residential Market...
- 576
PPG provides third quarter financial results update; reports soft demand conditions in Europe and China expected to continue into fourth quarter
PITTSBURGH–(BUSINESS WIRE)–PPG (NYSE:PPG) today announced that it expects third quarter 2022 adjusted earnings per diluted share to be between 5% and 7%...
- 535
Immune-Onc Therapeutics Enters into Clinical Collaboration with BeiGene in China
– Collaboration with BeiGene is part of Immune-Onc’s global clinical development strategy targeting the LILRB family of myeloid checkpoints – PALO ALTO,...
- 487
PPG provides third quarter financial results update; reports soft demand conditions in Europe and China expected to continue into fourth quarter
PITTSBURGH–(BUSINESS WIRE)–PPG (NYSE:PPG) today announced that it expects third quarter 2022 adjusted earnings per diluted share to be between 5% and 7%...
- 612
Phoenix Motorcars Engages IAT Automobile Technology to Advance Gen 4 Development
Accelerates development time, increases quality and reduces costs of Phoenix’s Gen 4 vehicles ANAHEIM, Calif.–(BUSINESS WIRE)–Phoenix Motor Inc. (Nasdaq: PEV) (“Company” or...
- 518
Immune-Onc Therapeutics Enters into Clinical Collaboration with BeiGene in China
– Collaboration with BeiGene is part of Immune-Onc’s global clinical development strategy targeting the LILRB family of myeloid checkpoints – PALO ALTO,...
